Psychopharmacology

Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic Profiles
by Michelle D. Po, PhD; Roberto Gomeni, PhD, HDR, FCP; and Bev Incledon, PhD Dr. Po is with Highland Therapeutics Inc. in Toronto, Ontario, Canada. Dr. Gomeni is with PharmacoMetrica France in La Fouillade, France and is an Adjunct Professor with the Division of Pharmacotherapy and Experimental Therapeutics in the UNC Eshelman School of Pharmacy at […]

Selective Serotonin Reuptake Inhibitors (SSRIs) and Their Effect on Patient Aggression in Adult Patients in a State Psychiatric Facility: A Retrospective Analysis
by Carolyn O’Donnell, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN; Drs. O’Donnell, Demler, and Trigoboff are with the State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice in Buffalo, New York. Drs. O’Donnell and Demler are with the New York State […]

Psychopharmacology in Pediatric Mixed Anxiety Disorder: An Evidence-based Review
by Sadiq Naveed, MD; Afshan Naz Amray, MD; Nusrat Jahan, MD; Fatima Bilal Moti-wala, MD; and Muhammad Hassan Majeed, MD Dr. Naveed is with the University of Kansas Medical Center in Kansas City, Kansas. Dr. Amray is with Dow University of Health Sciences in Karachi, Pakistan. Dr. Jahan is with Rush University Medical Center in […]

High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure
by Megan K. Skelly, PharmD, BCPS; Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; and Claudia Lee, MD Drs. Skelly, Demler, and Lee are with the State University at Buffalo (SUNY) School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice in Buffalo, New York and Drs. Demler and Lee are also with New York […]

Synthetic Cannabinoids—”Spice” Can Induce a Psychosis: A Brief Review
by Rajashekar Reddy Yeruva, MD; Hema Madhuri Mekala, MD; Meesha Sidhu MD; and Steven Lippmann, MD Drs. Yeruva and Lippmann are with the University of Louisville School of Medicine in Louisville, Kentucky. Drs. Mekala and Sidhu are with Griffin Memorial Hospital in Norman, Oklahoma. Funding: No funding was provided. Disclosures: The authors have no conflicts […]

Hot Topics in Neuroscience: Marijuana for Parkinson’s Disease?
by Diksha Mohanty, MD, and Steven Lippmann, MD Dr. Mohanty is Research Scholar and Dr. Lippmann is Emeritus Professor at the University of Louisville School of Medicine in Louisville, Kentucky. Funding: No funding was provided. Disclosures: The authors have no conflicts of interest relevant to the content of this article. Abstract: Marijuana is popular in […]

Lithium Suicide Prevention: A Brief Review and Reminder
by Simrat Kaur Sarai, MD; Hema Madhuri Mekala, MD; and Steven Lippmann, MD Drs. Sarai and Mekala are research scholars and Dr. Lippmann is Emeritus Professor for the Department of Psychiatry and Behavioral Sciences at University of Louisville School of Medicine in Louisville, Kentucky. Funding: No funding was provided. Disclosures: The authors have no conflicts […]

Worsening Choreoathetosis in Huntington’s Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report
By Clayton J. Hamilton, PharmD; Tysen K. Timmer, BA; Robert C. Munjal, MD; Fernando Cardozo-Pelaez, PhD; and Ian R. McGrane, PharmD Dr. Hamilton is with the Department of Pharmacy, Veteran’s Affairs Montana Medical Center-Fort Harrison, in Helena, Montana. Mr. Timmer is a third-year medical student at the University of Washington School of Medicine in Seattle, […]

Pimavanserin: A Novel Drug Approved to Treat Parkinson’s Disease Psychosis
by Amanda K. Kitten, PharmD; Sarah A. Hallowell, PharmD; Stephen Saklad, PharmD, BCPP; and Kirk E. Evoy, PharmD, BCACP, BC-ADM, CTTS Drs. Kitten, Hallowell, Saklad, and Evoy are with the College of Pharmacy, The University of Texas at Austin in Austin, Texas. Innov Clin Neurosci. 2017;15(1–2):16–22 FUNDING: The authors received no funding for the development […]